What are digitalis and inotropes?
Digitalis is a derivative of the foxglove plant used to treat heart failure and some heart rhythm problems (including atrial fibrillation). It increases the strength of the heart muscle's contractions, improving the heart's pumping ability, and slows down the heart's rhythm. In women with heart failure, digitalis does not improve survival, but it can relieve symptoms and reduce the need for hospitalization in patients whose symptoms are not controlled by standard treatment of an ACE inhibitor, a beta-blocker, and diuretics.1
Drugs that affect the strength of the heart's muscle contractions are called inotropes. Several other drugs in addition to digitalis have inotropic effects, but these have limited use in heart failure patients. They are given through an a line in your vein (intravenous, IV) and should only be used in the hospital in women with severe, late-stage heart failure (Stage D) when other drugs have failed to provide comfort.2
|Brand Names:||Lanoxin, Lanoxicaps, Digitek|
|How it is given:||By mouth (tablet, caplet, or liquid), injection (IV)|
|What it is used for:|
|You should not be treated with it if you:|| |
|You should be closely monitored if:|| |
|Pregnancy/nursing:||The effects of digitalis on the fetus are not known, so it should only be used if clearly needed and after the possible risks and benefits have been thoroughly evaluated with your doctor. Digitalis passes into breast milk, but in such small amounts that it is not likely to have an effect on the baby; however, it should be used carefully in women who are nursing.|
How does digitalis work?
Digitalis works in several ways. It works directly on the cardiac muscle by blocking an enzyme that controls the flow of sodium and potassium in and out of the heart muscle cells. This results in higher concentrations of calcium inside the cells, which signals the heart muscle to contract. More calcium means stronger heart muscle contractions.
Digitalis also works on the nervous system, signaling it to slow down the heart rate and slow down the speed that the heartbeat's electrical signal is transmitted through the heart, allowing the heart more time to fill with blood. The nervous system also signals the kidneys to deactivate certain kidney hormones, relaxing blood vessels and reducing the heart's workload.
Who should receive digitalis to prevent or treat heart failure?
Digitalis is not a first-choice drug for the treatment of heart failure. However, it may be useful in women with mild to moderate systolic heart failure who still have symptoms despite standard treatment with ACE inhibitors, diuretics, and beta-blockers.2 It can also be added at the beginning of treatment to get a quick response in women who have severe symptoms but in whom the standard drugs have not yet started having an effect.
In these women, digitalis can relieve symptoms, improve exercise capacity, improve the heart's pumping ability (measured by ejection fraction), and reduce the need for hospitalization. When blood levels of the drug are kept to a safe level, they do not appear to have any effect on survival.3 In the largest study so far, which included 6800 patients with systolic heart failure (22% were women), patients taking digoxin were nearly 30% less likely to be hospitalized for worsening heart failure.3 Results in women alone were not reported.
Digoxin is also used to treat women who have atrial fibrillation and systolic heart failure.2 The benefits of digitalis in women who have diastolic heart failure (blood filling problems) are not as clear, and few studies have examined their use in these patients.2 In one study of 916 patients (36% were women), researchers found that digoxin was just as effective in patients with diastolic heart failure as in those with systolic heart failure, reducing the need for hospitalization by 20%.4 However, another study of 988 patients (41% were women) found that digoxin did not reduce hospitalization in patients with mild to moderate diastolic heart failure compared with placebo.5 Neither study found that digoxin had an effect on survival, and neither reported results in women separately.
Does digitalis have different effects in women and men?
Since the original large studies of digoxin in heart failure treatment in the late 1990s, it has become apparent that different blood levels of the drug can have very different effects. Low levels are deemed safe and higher levels increase the risk of drug toxicity, which can lead to death.6 For this reason, it is very important that blood levels of this drug are carefully monitored and that all patients are given the lowest possible dose that controls symptoms. Based on current evidence, digoxin levels in the blood should be kept between 0.5 and 1.0 ng per mL to achieve the greatest benefits at minimal risk.2
Who should NOT receive digitalis?
Digitalis should not be used in women who have structural changes in the heart that indicate heart failure, but have not yet developed heart failure symptoms ( stage B heart failure) and do not have heart rhythm problems.2 In these women, the risks of the drugs outweigh the benefits.
These drugs should not be used or used carefully in women who have recently had a heart attack, especially if they still have reduced blood flow to the heart caused by narrowed or blocked vessels.2
Are there any alternative to digitalis?
The main alternatives to digitalis drugs to control heart failure symptoms that persist despite standard heart failure treatment are advanced therapies like pacemakers and intravenous inotropic drugs (in patients with severe symptoms).
My doctor has prescribed digitalis. What should I watch out for?
Digitalis drugs are generally very well tolerated, and produce side effects in only 1 in 100 patients.7 Still, establishing the appropriate dose of digitalis is extremely important, especially in women, since levels that are too high can actually increase a woman's risk of dying.6 You will need to have regular blood tests to measure the amount of the drug in your blood.
Because digitalis slows the conduction of the electrical impulses in the heart, the medication can sometimes interfere with the normal heartbeat, causing irregular or skipped beats, or even causing the electrical signal not to reach the entire heart (known as heart block). This can usually be avoided by carefully tailoring the dose to your body and medical profile.
|Digitalis Side Effects To Watch For|
|Immediately contact your doctor to have your dose adjusted if you experience: |
Certain other medications can interact with digoxin and its affects, so you should be started on the drug carefully if you are already taking beta blockers, certain heart rhythm drugs such as amiodarone (Pacerone/Cordarone), verapamil, or quinidine, antibiotics (including azithromycin, clarithromycin, erythromycin), or antifungals (itraconazole, ketoconazole).2
- Gheorghiade M, Adams KF, Jr., Colucci WS. Digoxin in the management of cardiovascular disorders. Circulation. Jun 22 2004;109(24):2959-2964.
- Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. Apr 14 2009;53(15):e1-e90.
- The Digitalis Investigation Group. The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure. N Engl J Med. February 20, 1997 1997;336(8):525-533.
- Meyer P, White M, Mujib M, et al. Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure. Am J Cardiol. Dec 15 2008;102(12):1681-1686.
- Ahmed A, Rich MW, Fleg JL, et al. Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial. Circulation. August 1, 2006 2006;114(5):397-403.
- Adams KF, Jr., Patterson JH, Gattis WA, et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. J Am Coll Cardiol. Aug 2 2005;46(3):497-504.
- Steiner JF, Robbins LJ, Hammermeister KE, Roth SC, Hammond WS. Incidence of digoxin toxicity in outpatients. West J Med. Nov 1994;161(5):474-478.